What are the adverse effects of gentamicin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Gentamicin Adverse Effects

Gentamicin causes three major adverse effects: nephrotoxicity (most common), ototoxicity (most serious), and neurotoxicity, with risk increasing substantially with cumulative dose, prolonged therapy, advanced age, and pre-existing renal impairment.

Primary Adverse Effects

Nephrotoxicity

Nephrotoxicity is the most frequently encountered adverse effect of gentamicin 1:

  • Incidence: Occurs in approximately 2-8.7% of patients, with higher rates in those with risk factors 2, 1
  • Manifestations: Rising BUN, serum creatinine, oliguria, presence of casts/cells/protein in urine
  • Reversibility: The large majority of cases are reversible, particularly with single-dose regimens 3
  • Risk factors:
    • Pre-existing renal impairment (especially dialysis patients)
    • Longer treatment duration or higher cumulative doses
    • Concurrent nephrotoxic agents
    • Advanced age (>60 years)
    • Female sex
    • Higher body weight
    • ICU admission
    • Concurrent CT contrast imaging 4

Critical caveat: Gentamicin should be avoided entirely in patients >60 years of age due to sharply increased risk of kidney injury 4.

Ototoxicity

Ototoxicity represents the most serious adverse effect due to potential irreversibility 2, 5, 1:

  • Types: Both vestibular dysfunction (dizziness, vertigo) and auditory damage (tinnitus, hearing loss)
  • Incidence: Ranges from 1.5-24% depending on dose and duration, with hearing loss at 3% in neonates 2, 5, 6
  • Characteristics:
    • Hearing loss typically begins with high-frequency diminution
    • May be irreversible
    • Risk increases dramatically with cumulative doses >100-120 g
  • Risk factors:
    • Advanced age
    • Concurrent loop diuretics (furosemide, ethacrynic acid)
    • Prolonged therapy
    • Higher single doses
    • Pre-existing renal impairment

Neurotoxicity

Less common but clinically significant 2, 5, 1:

  • Common: Circumoral paresthesias immediately post-injection
  • Rare but serious:
    • Peripheral neuropathy
    • Encephalopathy (numbness, muscle twitching, convulsions)
    • Myasthenia gravis-like syndrome
    • Respiratory depression
    • Interaction with muscle relaxants causing postoperative respiratory weakness

Secondary Adverse Effects

Additional reported reactions include 1:

  • Hypersensitivity: Rash, urticaria, anaphylactoid reactions, fever
  • Gastrointestinal: Nausea, vomiting, stomatitis
  • Hematologic: Anemia, leukopenia, thrombocytopenia, eosinophilia
  • Electrolyte disturbances: Hypomagnesemia, hypocalcemia, hypokalemia (may cause tetany and muscle weakness)
  • Hepatic: Increased transaminases, LDH, bilirubin
  • Local: Pain at injection site (rare), subcutaneous atrophy

Special Populations

Pregnancy

Gentamicin is absolutely contraindicated in pregnancy due to risk of fetal nephrotoxicity and congenital hearing loss 2, 5, 2.

Renal Impairment

Dosing adjustments are essential 2, 5:

  • Reduce dosing frequency to 2-3 times weekly when creatinine clearance <50 mL/min
  • Maintain mg/kg dose at 12-15 mg/kg to preserve concentration-dependent bactericidal effect
  • Administer after dialysis
  • Monitor serum drug concentrations mandatory

Elderly Patients

  • Reduce maximum daily dose to 10 mg/kg (750 mg) for patients >59 years 2, 5
  • Consider avoiding gentamicin entirely in patients >60 years 4

Risk Mitigation Strategies

Monitoring Requirements

Baseline assessments 2, 5:

  • Audiogram and vestibular testing
  • Romberg testing
  • Serum creatinine

Monthly monitoring:

  • Renal function assessment
  • Questioning regarding auditory/vestibular symptoms
  • Repeat audiogram if symptoms develop

Dosing Considerations

For enterococcal endocarditis specifically 7:

  • Multiple divided doses (total ≈3 mg/kg/day) preferred over single daily dosing
  • Target 1-hour serum concentration ≈3 μg/mL, trough <1 μg/mL
  • Consider limiting gentamicin duration to 2 weeks to minimize toxicity while maintaining efficacy 8
  • Gentamicin-associated nephrotoxicity may complicate 4-6 week courses and could result in life-threatening complications including hemodialysis requirement 7

Circadian Considerations

Emerging evidence suggests toxicity varies with circadian timing of administration, with treatment at the beginning of the rest span (14 hours after lights on) showing reduced ototoxicity and nephrotoxicity compared to treatment at the beginning of the activity span 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.